Sandra Gisele Marshall

Array ( [id] => 3973574 [patent_doc_number] => 05948388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Chewable softgel oral hygiene product' [patent_app_type] => 1 [patent_app_number] => 9/096808 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 625 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948388.pdf [firstpage_image] =>[orig_patent_app_number] => 096808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4142910 [patent_doc_number] => 06030943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Dehydrodidemnin B as an L-type calcium channel enhancer' [patent_app_type] => 1 [patent_app_number] => 9/073288 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3877 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030943.pdf [firstpage_image] =>[orig_patent_app_number] => 073288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975411 [patent_doc_number] => 05916873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Teicoplanin derivatives' [patent_app_type] => 1 [patent_app_number] => 9/053848 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3013 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916873.pdf [firstpage_image] =>[orig_patent_app_number] => 053848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022596 [patent_doc_number] => 05925618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Peptides useful as somatostatin antagonists' [patent_app_type] => 1 [patent_app_number] => 9/033395 [patent_app_country] => US [patent_app_date] => 1998-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5846 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925618.pdf [firstpage_image] =>[orig_patent_app_number] => 033395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081630 [patent_doc_number] => 06017545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Mixed micellar delivery system and method of preparation' [patent_app_type] => 1 [patent_app_number] => 9/021114 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8527 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017545.pdf [firstpage_image] =>[orig_patent_app_number] => 021114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038014 [patent_doc_number] => 05856436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Depsipeptide derivative, process for production thereof, and novel intermediate therefor' [patent_app_type] => 1 [patent_app_number] => 8/973718 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7026 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856436.pdf [firstpage_image] =>[orig_patent_app_number] => 973718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3966161 [patent_doc_number] => 05885959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Cyclic peptide compounds and their production process' [patent_app_type] => 1 [patent_app_number] => 8/999627 [patent_app_country] => US [patent_app_date] => 1997-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3317 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885959.pdf [firstpage_image] =>[orig_patent_app_number] => 999627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010879 [patent_doc_number] => 05889146 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method for synthesis of bifunctional chelating agents-peptides' [patent_app_type] => 1 [patent_app_number] => 8/978615 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2233 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889146.pdf [firstpage_image] =>[orig_patent_app_number] => 978615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874031 [patent_doc_number] => 05824646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Intravaginal delivery of biologically active polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/971329 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7332 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824646.pdf [firstpage_image] =>[orig_patent_app_number] => 971329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045768 [patent_doc_number] => 05908830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Combination therapy for the treatment of diabetes and obesity' [patent_app_type] => 1 [patent_app_number] => 8/961749 [patent_app_country] => US [patent_app_date] => 1997-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9553 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908830.pdf [firstpage_image] =>[orig_patent_app_number] => 961749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008227 [patent_doc_number] => 05888970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Technetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents' [patent_app_type] => 1 [patent_app_number] => 8/940825 [patent_app_country] => US [patent_app_date] => 1997-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16971 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888970.pdf [firstpage_image] =>[orig_patent_app_number] => 940825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890116 [patent_doc_number] => 05834420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation' [patent_app_type] => 1 [patent_app_number] => 8/765838 [patent_app_country] => US [patent_app_date] => 1997-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4077 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834420.pdf [firstpage_image] =>[orig_patent_app_number] => 765838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3960607 [patent_doc_number] => 05900402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Method of reducing side effects associated with administration of oxygen-carrying proteins' [patent_app_type] => 1 [patent_app_number] => 8/865035 [patent_app_country] => US [patent_app_date] => 1997-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5139 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900402.pdf [firstpage_image] =>[orig_patent_app_number] => 865035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4020000 [patent_doc_number] => 05907035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Aqueous two-phase metal affinity partitioning protein purification system' [patent_app_type] => 1 [patent_app_number] => 8/861587 [patent_app_country] => US [patent_app_date] => 1997-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9695 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907035.pdf [firstpage_image] =>[orig_patent_app_number] => 861587 [rel_patent_id] =>[rel_patent_doc_number] =>)